The autonomic nervous system (ANS) is the branch of the peripheral nervous system responsible for regulating involuntary physiological functions essential for homeostasis[1]. Unlike the somatic nervous system, which controls voluntary movements, the ANS operates largely unconsciously to coordinate cardiovascular activity, gastrointestinal motility, respiratory function, thermoregulation, pupillary response, and glandular secretion[1:1][2]. The ANS is divided into three major subdivisions: the sympathetic nervous system (SNS), the parasympathetic nervous system (PNS), and the enteric nervous system (ENS), each with distinct anatomical organization and functional roles[2:1].
The sympathetic division, often called the "fight-or-flight" system, originates from thoracolumbar spinal segments (T1-L2) and mediates stress responses through norepinephrine and epinephrine release from the adrenal medulla[2:2]. The parasympathetic division, the "rest-and-digest" system, arises from cranial nerves (III, VII, IX, X) and sacral segments (S2-S4), primarily using acetylcholine as its neurotransmitter[2:3]. The enteric nervous system, a complex mesh of neurons embedded in the gastrointestinal tract wall, can operate semi-independently but is modulated by both sympathetic and parasympathetic input[3].
Autonomic control originates in the hypothalamus, which serves as the master regulator of autonomic function through its connections to brainstem autonomic nuclei and the spinal cord[1:2][4]. The hypothalamus integrates sensory information regarding internal milieu (blood pressure, body temperature, osmolality) and coordinates appropriate autonomic responses through downstream pathways[4:1]. The insular cortex, amygdala, and prefrontal cortex also contribute to autonomic regulation, particularly in emotional and cognitive contexts[4:2].
The central autonomic network (CAN) encompasses several brain regions that collectively regulate autonomic function[2:4][5]:
The sympathetic pathway involves preganglionic neurons in the intermediolateral cell column of the spinal cord, which project to sympathetic ganglia in the chain along the vertebral column or prevertebral ganglia in the abdomen[2:5]. Postganglionic fibers then innervate target organs including the heart, blood vessels, lungs, and viscera[2:6]. The parasympathetic pathway has preganglionic neurons in brainstem nuclei and sacral spinal cord, which project to terminal ganglia located near or within target organs, where short postganglionic fibers complete the circuit[2:7].
The brainstem contains critical autonomic nuclei that mediate cardiovascular, respiratory, and gastrointestinal function[6][7]:
The ANS employs a diverse repertoire of neurotransmitters and receptors for signal transmission[2:8]. Preganglionic neurons in both divisions release acetylcholine onto nicotinic receptors on postganglionic neurons[2:9]. Postganglionic sympathetic neurons primarily release norepinephrine onto alpha- and beta-adrenergic receptors, while parasympathetic postganglionic neurons release acetylcholine onto muscarinic receptors[2:10]. The enteric nervous system uses numerous neurotransmitters including serotonin, dopamine, nitric oxide, and various neuropeptides[3:1][8].
| Receptor Type | Ligand | Distribution | Function |
|---|---|---|---|
| Nicotinic (AChR) | Acetylcholine | Autonomic ganglia | Fast excitatory transmission |
| Muscarinic M3 | Acetylcholine | Smooth muscle, glands | Contraction, secretion |
| Muscarinic M2 | Acetylcholine | Heart | Negative chronotropy |
| Alpha-1 adrenergic | Norepinephrine | Vascular smooth muscle | Vasoconstriction |
| Beta-1 adrenergic | Norepinephrine | Heart | Increased rate/contractility |
| Beta-2 adrenergic | Norepinephrine | Bronchi, vasculature | Bronchodilation |
One of the most influential concepts linking the ANS to neurodegenerative disease is the Braak hypothesis, which proposes that alpha-synuclein pathology in Parkinson's disease may originate in the gastrointestinal tract and propagate retrogradely through vagal nerve fibers to the central nervous system[9][10]. This hypothesis is supported by:
The enteric nervous system is particularly vulnerable in synucleinopathies[8:2]. The ENS contains millions of neurons embedded in the gut wall, forming a semi-autonomous network that controls gastrointestinal motility, secretion, and blood flow[3:2]. In Parkinson's disease:
Autonomic dysfunction is a hallmark feature of several neurodegenerative diseases, particularly the synucleinopathies[12][13]. In Parkinson's disease, autonomic failure often manifests early and may precede motor symptoms by years or decades[12:1]. Orthostatic hypotension, constipation, urinary dysfunction, and sudomotor abnormalities are common manifestations resulting from degeneration of autonomic neurons in the peripheral and central nervous systems[12:2].
Multiple system atrophy (MSA) presents with prominent autonomic failure alongside cerebellar or parkinsonian features, reflecting the progressive loss of autonomic neurons in brainstem and spinal cord nuclei[13:1][14]. Pure autonomic failure involves selective degeneration of peripheral autonomic neurons without central involvement[13:2][15]. In dementia with Lewy bodies, autonomic dysfunction correlates with the presence of synuclein pathology in autonomic pathways[12:3].
Cardiovascular autonomic dysfunction manifests through several patterns[16][17]:
Gastrointestinal involvement in neurodegenerative disease includes[8:3]:
Bladder dysfunction in neurodegenerative disease involves[18]:
Sweating abnormalities are common in PD and related disorders[19]:
While traditionally considered less prominent than in synucleinopathies, autonomic dysfunction also occurs in Alzheimer's disease[20][21]:
Autonomic involvement in ALS includes[22]:
MSA represents the most severe form of autonomic failure among neurodegenerative disorders[13:3][14:1]:
The neuropathological correlates of autonomic dysfunction in neurodegenerative disease reflect the distribution of pathology[23][24]:
In synucleinopathies, phosphorylated alpha-synuclein forms inclusions throughout the autonomic nervous system[24:1][8:4]:
Clinical evaluation of autonomic function includes[25]:
Treatment of autonomic dysfunction in neurodegenerative disease is primarily symptomatic and includes[25:1]:
For Orthostatic Hypotension:
For Gastrointestinal Dysmotility:
For Bladder Dysfunction:
For Sudomotor Dysfunction:
The sympathetic nervous system (SNS) originates from thoracolumbar segments (T1-L2) of the spinal cord and mediates the "fight-or-flight" response[2:11]. Preganglionic neurons are located in the intermediolateral cell column and project to sympathetic ganglia either in the sympathetic chain (paravertebral ganglia) or prevertebral ganglia (celiac, superior mesenteric, inferior mesenteric)[2:12].
The sympathetic system innervates virtually every organ system:
Sympathetic preganglionic neurons release acetylcholine onto nicotinic receptors on postganglionic neurons[2:13]. Most postganglionic neurons release norepinephrine as their primary neurotransmitter, with the exception of sweat glands, which use acetylcholine[2:14].
The adrenal medulla is a specialized sympathetic organ that is innervated by preganglionic fibers and releases epinephrine and norepinephrine directly into the bloodstream, acting as an endocrine gland[2:15].
Sympathetic dysfunction in neurodegenerative disease manifests as:
The parasympathetic nervous system (PNS) arises from cranial nerves III, VII, IX, and X, and sacral segments S2-S4[2:16]. It mediates "rest-and-digest" functions through longer preganglionic fibers and shorter postganglionic fibers, with ganglia located near or within target organs[2:17].
Key parasympathetic outflows include:
Both preganglionic and postganglionic parasympathetic neurons release acetylcholine[2:18]. Postganglionic neurons act on muscarinic receptors:
Parasympathetic dysfunction contributes to:
The standard battery of cardiovascular autonomic tests includes[25:2][17:1]:
Heart Rate Tests:
Blood Pressure Tests:
Sudomotor function is assessed through several methods[19:1]:
Baroreflex function can be evaluated through:
Plasma catecholamine measurements provide insights into autonomic function[25:3]:
Autonomic nervous system dysfunction in neurodegenerative disease. Journal of Neurology. 2019. ↩︎ ↩︎ ↩︎
Central autonomic network. Neuroanatomy. 2013. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Enteric nervous system: A second brain. Medscape. 2004. ↩︎ ↩︎ ↩︎
Hypothalamic regulation of autonomic function. Neuroscience. 2018. ↩︎ ↩︎ ↩︎
Autonomic networks in the brain. Neurology. 2018. ↩︎
Brainstem circuitry for autonomic responses to stress. Neuroscience. 2019. ↩︎
Brainstem pathology in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry. 1988. ↩︎
Enteric nervous system in Parkinson's disease. Nature Reviews Gastroenterology & Hepatology. 2021. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Idiopathic Parkinson's disease may originate from the gut. Journal of Neural Transmission. 2003. ↩︎
Alpha-synuclein in gastrointestinal mucosa. Movement Disorders. 2014. ↩︎
Medical records and positive serology for constipation preceding Parkinson disease. Neurology. 2016. ↩︎
Autonomic dysfunction in Parkinson's disease. Nature Reviews Neurology. 2020. ↩︎ ↩︎ ↩︎ ↩︎
Multiple system atrophy and pure autonomic failure. Lancet Neurology. 2019. ↩︎ ↩︎ ↩︎ ↩︎
Multiple system atrophy and autonomic failure. Movement Disorders. 2015. ↩︎ ↩︎
Pure autonomic failure. Current Neurology and Neuroscience Reports. 2014. ↩︎
Heart rate variability in Parkinson's disease. Journal of Parkinson's Disease. 2019. ↩︎
Orthostatic hypotension and the central autonomic network. Journal of Internal Medicine. 2006. ↩︎ ↩︎
Bladder dysfunction in Parkinson's disease. Parkinsonism and Related Disorders. 2018. ↩︎
Sudomotor dysfunction in Parkinson disease. Neurology. 2022. ↩︎ ↩︎
Cardiovascular autonomic dysfunction in Alzheimer's disease. Journal of Alzheimer's Disease. 2015. ↩︎
Autonomic dysfunction in neurodegenerative dementia. Dementia and Geriatric Cognitive Disorders. 2017. ↩︎
Dysautonomia in amyotrophic lateral sclerosis. Journal of Neurology. 2014. ↩︎
Prevalence of neuropathological changes in Parkinson's disease. Journal of Neural Transmission. 2003. ↩︎
Autonomic failure with alpha-synuclein pathology. Annals of Neurology. 2019. ↩︎ ↩︎
Management of autonomic dysfunction in Parkinson's disease. Movement Disorders. 2022. ↩︎ ↩︎ ↩︎ ↩︎